HYHai Yang

Hai Yang

*This is an algorithmically generated author record based on publicly available information.

Hai Yang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Bingshan Li

    Department of Molecular Physiology and Biophysics, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, USA

    2 shared publications
  • Qiang Wei

    Department of Molecular Physiology & Biophysics, Nashville, TN, USA

    2 shared publications
  • Xue Zhong

    Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA

    2 shared publications
  • Guangze Zheng

    Department of Molecular Physiology & Biophysics, Nashville, TN, USA

    1 shared publication
  • Hushan Yang

    Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

    1 shared publication
  • Nancy J Cox

    Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA

    1 shared publication

Latest Publications

  • De novopattern discovery enables robust assessment of functional consequences of non-coding variants

    by Hai Yang, Rui Chen, Quan Wang, Qiang Wei, Ying Ji, Guangze Zheng, Xue Zhong, Nancy J Cox, Bingshan Li

    Given the complexity of genome regions, prioritize the functional effects of noncoding variants remains a challenge. Although several frameworks have been proposed for the evaluation of the functionality of noncoding variants, most of them used "black boxes" methods that simplify the task as the pathogenicity/benign classification problem, which ignores the distinct regulatory mechanisms of variants and leads to less desirable performance. In this study, we developed DVAR, an unsupervised framework that leverage various biochemical and evolutionary evidence to distinguish the gene regulatory categories of variants and assess their comprehensive functional impact simultaneously. DVAR performed de novo pattern discovery in high-dimensional data and identified five regulatory clusters of noncoding variants. Leveraging the new insights into the multiple functional patterns, it measures both the between-class and the within-class functional implication of the variants to achieve accurate prioritization. Compared to other two-class learning methods, it showed improved performance in identification of clinically significant variants, fine-mapped GWAS variants, eQTLs and expression-modulating variants. Moreover, it has superior performance on disease causal variants verified by genome editing (like CRISPR-Cas9), which could provide a pre-selection strategy for genome editing technologies across the whole genome. Finally, evaluated in BioVU and UK Biobank, two large-scale DNA biobanks linked to complete electronic health records (EHR), DVAR demonstrated its effectiveness in prioritizing noncoding variants associated with medical phenotypes. The C++ and Python source codes, the pre-computed DVAR-cluster labels and DVAR scores across the whole genome are available at https://www.vumc.org/cgg/dvar. Supplementary data are available at Bioinformatics online.


  • Open Access

    Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework

    by Hai Yang, Qiang Wei, Xue Zhong, Hushan Yang, Bingshan Li

    Comprehensive catalogue of genes that drive tumor initiation and progression in cancer is key to advancing diagnostics, therapeutics and treatment. Given the complexity of cancer, the catalogue is far from complete yet. Increasing evidence shows that driver genes exhibit consistent aberration patterns across multiple-omics in tumors. In this study, we aim to leverage complementary information encoded in each of the omics data to identify novel driver genes through an integrative framework. Specifically, we integrated mutations, gene expression, DNA copy numbers, DNA methylation and protein abundance, all available in The Cancer Genome Atlas (TCGA) and developed iDriver, a non-parametric Bayesian framework based on multivariate statistical modeling to identify driver genes in an unsupervised fashion. iDriver captures the inherent clusters of gene aberrations and constructs the background distribution that is used to assess and calibrate the confidence of driver genes identified through multi-dimensional genomic data. We applied the method to 4 cancer types in TCGA and identified candidate driver genes that are highly enriched with known drivers. (e.g.: P < 3.40 × 10−36 for breast cancer). We are particularly interested in novel genes and observed multiple lines of supporting evidence. Using systematic evaluation from multiple independent aspects, we identified 45 candidate driver genes that were not previously known across these 4 cancer types. The finding has important implications that integrating additional genomic data with multivariate statistics can help identify cancer drivers and guide the next stage of cancer genomics research. The C ++ source code is freely available at https://medschool.vanderbilt.edu/cgg/. Supplementary data are available at Bioinformatics online.